Eggen, Annemarie C.
Hospers, Geke A. P.
Bosma, Ingeborg
Kramer, Miranda C. A.
Reyners, Anna K. L.
Jalving, Mathilde http://orcid.org/0000-0002-9142-9050
Article History
Received: 26 April 2021
Accepted: 20 February 2022
First Online: 5 March 2022
Declarations
:
: The UMCG ethical review board granted ethical approval and waived the need for an informed consent procedure (METc2017/511). The “opt-out” register was assessed to exclude patients that disapproved of routinely collected data being used for research purposes.
: Not applicable.
: GAPH is a consultant/advisory board member for Amgen, Roche, Merck, Bristol-Myers Squibb, Pfizer, Novartis, and Pierre Fabre, and has received grants from Bristol-Myers Squibb and Seerave, outside the submitted work and paid to the institution. MJ has served as an advisory board member for Bristol-Myers Squibb, Novartis, Merck, and Pierre Fabre, fees paid to the institution. The other authors declare that they have no competing interests.